首页> 美国卫生研究院文献>European Spine Journal >Transpedicle body augmenter in painful osteoporotic compression fractures
【2h】

Transpedicle body augmenter in painful osteoporotic compression fractures

机译:经椎弓根体增强器治疗疼痛性骨质疏松性压缩性骨折

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Osteoporotic compression fractures (VCFs) can result in progressive kyphosis and chronic pain. Polymethylmethacrylate has been used for augmentation of VCFs; however, there are cement complications, and long-term fracture healing is unknown. The transpedicle body augmenter (TpBA), a porous titanium spacer, has been reported as an internal support to reconstruct the vertebral body combining short segment fixation in burst fracture. We retrospectively reviewed radiographic and clinical results of TpBA vertebroplasty for single symptomatic VCF in 80 patients. Manual reduction and TpBA vertebroplasty via a paramedian incision with blunt dissection was done. Mean age was 72.3 years (range 51–87 years), and female–male ratio was 66:14. The mean symptom duration was 5 months, and follow-up 44 months. Peri-operative variables and radiographic and clinical results were evaluated. The average operation time was 26.1 min, blood loss 92 cc, and hospitalization 2.3 days. No patient had neurological deterioration. TpBA was found sinking into vertebral body initially, then locked by residual cortex, and finally stabilized within the vertebra. There was no dislodgement of TpBA in the final visit. Sixty-two patients (77.5%) could walk within 3–6 h after operation and the others within 24 h. The anterior vertebral restoration was 8.0 mm initially and 6.1 mm at final follow-up. Wedge angle correction was 11.5° initially and 9.4° at final follow-up. Pain, by the visual analog scale, was 8.6 pre-operatively, 2.5 at day 7 follow-up, and 2.9 at final follow-up. By the questionnaire, 72 of 76 respondents reported a decrease in discomfort after TpBA vertebroplasty, and 63 of 76 patients reported a return to normal activity after operation. The final satisfaction rate was 93.4%. TpBA vertebroplasty led to early and medium-term clinical improvement and anatomic restoration of painful VCFs.
机译:骨质疏松性压缩性骨折(VCF)可导致进行性后凸畸形和慢性疼痛。聚甲基丙烯酸甲酯已被用于增强VCF。但是,存在骨水泥并发症,长期骨折的愈合尚不清楚。经椎弓根体增强器(TpBA),一种多孔的钛间隔物,已被报道为在爆裂性骨折中结合短节段固定来重建椎体的内部支撑。我们回顾性分析了80例患者的TpBA椎体成形术治疗单症状VCF的影像学和临床结果。进行手法复位和TpBA椎体成形术,通过正中切口切开钝性夹层。平均年龄为72.3岁(范围为51-87岁),男女之比为66:14。平均症状持续时间为5个月,随访44个月。评估围手术期变量以及影像学和临床结果。平均手术时间为26.1分钟,失血92 cc,住院2.3天。没有患者神经功能恶化。发现TpBA最初沉入椎体内,然后被残余皮质锁定,最终稳定在椎骨内。在最后的访问中没有撤出TpBA。六十二名患者(77.5%)可以在术后3–6小时内行走,其他患者可以在24小时内行走。最初的椎体修复为8.0mm,最后的随访为6.1mm。楔角校正最初为11.5°,而最终随访为9.4°。通过视觉模拟评分,术前疼痛为8.6,第7天为2.5,最终为2.9。通过问卷调查,在76位受访者中,有72位报告说TpBA椎体成形术后不适感有所减轻,在76位患者中,有63位报告说手术后恢复了正常活动。最终满意率为93.4%。 TpBA椎体成形术导致了早期和中期临床改善以及疼痛性VCF的解剖学修复。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号